Search results

Ethos slams Novartis for advisory vote on sustainability report at AGM

2024-02-16T10:30:00Z

‘There is no doubt’ that a binding vote is necessary, says foundation

Ethos opposes Novartis’ proposal of virtual-only AGMs

2023-02-21T14:46:00Z

The foundation is in favour instead of ‘hybrid’ AGMs

Ethos finds shortfalls in Nestlé’s sustainability report

2024-04-05T10:00:00Z

The company is failing to disclose sufficient detail in particular on Scope 3 emissions

Swiss 1e pension plans spark appetite for younger generations

2020-08-21T14:43:00Z

Large companies with 1e solutions include CS and Novartis

​Swedish pension funds warn companies against digital-only AGMs

2024-02-20T09:00:00Z

Alecta, AMF, AP funds say will vote down proposals to axe obligation to hold physical shareholder meetings

Large Swiss firms fail to assess impact of digital transformation on workforce

2023-12-19T14:46:00Z

However, Switzerland’s largest listed companies researched in Ethos study have improved their scores with regard to digital responsibly

A closer look at European equities

Reference Hub2024-10-01T00:16:00ZBy STOXX

Interview with Arun Singhal, Global Head of Product Management at STOXX.

Novartis misses benchmark

2007-05-30T16:02:55Z

SWITZERLAND – Novartis’ CHF14.3bn (€8.7bn) pension fund has reported a return of just 2% for 2006 – below both the 6.6% average for other Swiss schemes and its own 3% benchmark.

CEO commitment on mental health lacking, CCLA global benchmark shows

2023-10-10T09:46:00Z

There is a clear economic case for investment in mental health at work, says CCLA stewardship lead

Switzerland's Ethos presses for review of Novartis' remuneration policy

2011-02-22T15:15:00Z

Foundation argued that remuneration should not reward risk-taking.

Pensionskasse Post boosts infrastructure, real estate investments

2023-08-29T13:45:00Z

The scheme allocated CHF100m for impact investments in infrastructure

Ethos plans Novartis revolt

2007-02-21T16:36:57Z

SWITZERLAND – Socially-responsible manager Ethos says it will oppose the re-election of a senior official at the Swiss pharmaceuticals giant Novartis during the firm’s annual shareholder meeting on March 6.

Oxfam starts Novartis campaign

2007-01-23T16:53:29Z

UK – Responsible investment campaigners FairPensions and international development agency Oxfam, have asked institutional investors to use their shareholder rights to put pressure on pharmaceutical firms.

Cometa opposes CEO remuneration, but in favour of labour rights at AGMs

2023-03-03T15:30:00Z

The Italian pension fund has opposed high pay, or pay not linked to ESG goals, of managers at Siemens, Deere & Co, and Compass Group

Switzerland: Workplace pension reform faces referendum test

Top 1000 Pension Funds 2024

The country is introducing regulations on greenwashing and fund investments, while debating how to fund the first and second-pillar pension systems

New head at €8bn Novartis scheme

2006-10-10T16:11:56Z

SWITZERLAND – Gino Pfister has stepped down as director of the Novartis pension fund, one of Switzerland’s biggest with CHF14.6bn (€8.6bn) in assets.

Better the equity market devil you know?

June 2023 (Magazine)

Being a large equity investor in a relatively small domestic market can have advantages as well as drawbacks. Proximity to the market and its infrastructure, good knowledge of corporates and corporate leaders, and the ability to exercise strong influence as an owner, potentially a stable long-term one, all count among the advantages. The need to avoid concentration – in terms of position, sizing and overall allocations – and idiosyncratic sector exposure are among the challenges. 

Novartis pension fund returns 6.2%

2006-06-02T03:39:00Z

SWITZERLAND – Novartis’ pension fund, one of Switzerland’s biggest with CHF14.6bn (€9.3bn) in assets, has reported a return of 6.2% for 2005 - well below the 11% average for other Swiss schemes.

Novartis shifts from 'bricks and mortar'

December 2002 (Magazine)

The SFr16.8bn (e11.4bn) pension scheme of Swiss pharmaceutical giant, Novartis, holds real estate assets that comprise 12% of the fund’s assets. Earlier this year, it completed a major transition in the approach to its property portfolio, which allowed the fund to maintain its exposure to this asset class, while enabling ...

Novartis ready for the euro

May 1998 (Magazine)